Skip to main content
PT Diagnos Laboratorium Utama Tbk logo

PT Diagnos Laboratorium Utama Tbk — Investor Relations & Filings

Ticker · DGNS ISIN · ID1000158702 IDX Human health and social work activities
Open in API
Filings indexed 17 across all filing types
Latest filing 2026-06-08 Share Issue/Capital Cha…
Country ID Indonesia
Listing IDX DGNS

About PT Diagnos Laboratorium Utama Tbk

https://diagnos.co.id/

PT Diagnos Laboratorium Utama Tbk provides comprehensive health services through its laboratories. As part of the Bundamedik Healthcare System, the company offers a wide range of integrated clinical and genomic laboratory tests, including general health screenings, specialized diagnostics for infectious diseases, cancer risk assessment, and advanced genetic analyses like DNA and gut microbiota profiling. Services encompass medical check-ups, doctor consultations, and convenient homecare options, utilizing advanced technology to deliver fast, accurate, and reliable results for individuals and corporate clients.

Recent filings

Filing Released Lang Actions
Pencatatan Saham
Share Issue/Capital Change Classification · 85% confidence The document is an official Indonesia Stock Exchange announcement regarding the listing of newly issued shares without preemptive rights (penambahan modal tanpa HMETD). It details the number of shares issued, exercise price, and listing date, which is a capital change event. This matches the Share Issue/Capital Change category.
2026-06-08 Indonesian
Penambahan Modal Tanpa HMETD Rencana Pelaksanaan Penambahan Modal Tanpa HMETD
Share Issue/Capital Change Classification · 93% confidence The document is an official notification by PT Diagnos Laboratorium Utama Tbk detailing the Implementation Plan for a Capital Increase without Preemptive Rights. It provides specific share numbers, nominal value, exercise price, total capital increase, effective dates, and related details. This aligns exactly with a Share Issue/Capital Change announcement rather than a full financing report or earnings release.
2026-05-26 Indonesian
Pemanggilan Rapat Umum Pemegang Saham Tahunan dan Luar Biasa (KOREKSI)
Regulatory Filings Classification · 72% confidence The document is an official announcement (invitation) calling for the Annual and Extraordinary General Meeting of Shareholders, including date, venue, recording date and agenda items. It is not the full meeting materials (which would be a proxy statement under PSI) but rather a regulatory notice of the meeting itself. It does not contain financial statements or voting results, nor is it a report on performance. It fits best as a general regulatory filing (Regulatory Filings - RNS).
2026-05-25 Indonesian
Pemanggilan Rapat Umum Pemegang Saham Tahunan dan Luar Biasa (KOREKSI)
Proxy Solicitation & Information Statement Classification · 87% confidence The document is a formal invitation (“Pemanggilan RUPS”) for the company’s Annual and Extraordinary General Meeting of Shareholders, including agenda items and recording date. It is not the actual annual report, not a financial statement, and not reporting vote results. It is a solicitation of proxies/attendance for the shareholders’ meeting, which aligns with the Proxy Solicitation & Information Statement category (PSI).
2026-05-25 Indonesian
Penjelasan atas Volatilitas Transaksi
Regulatory Filings Classification · 92% confidence The document is a formal letter from PT Diagnos Laboratorium Utama Tbk responding to a request by the Indonesia Stock Exchange for an explanation of unusually volatile trading. It outlines compliance with disclosure regulations (POJK), answers questions on material facts, shareholding activities, and corporate actions. It is not a financial report or management presentation, nor a dividend, merger, or board change notice. It is a miscellaneous regulatory disclosure filing and thus best fits the Regulatory Filings category (RNS).
2026-05-18 Indonesian
Penyampaian Bukti Iklan Pengumuman Rapat Umum Pemegenag Saham Tahunan dan Luar Biasa
Regulatory Filings Classification · 90% confidence The document is a short, formal announcement (“bukti iklan”) providing proof that the company has published notices of its Annual and Extraordinary General Meetings of Shareholders on various media. It contains no financial statements, proxy materials, or meeting presentations, nor does it request shareholder votes or report voting results. It does not itself constitute an AGM presentation, earnings release, or financial report but is a routine regulatory announcement under Indonesian exchange rules. Therefore, it falls under the general "Regulatory Filings" category.
2026-05-15 Indonesian

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.